Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.74B | 1.58B | 1.45B | 1.39B | 1.11B | 1.05B |
Gross Profit | 1.01B | 886.10M | 802.34M | 727.35M | 623.15M | 561.95M |
EBITDA | 406.95M | 335.56M | 326.29M | 264.45M | 210.80M | 345.70M |
Net Income | 232.27M | 136.78M | 93.36M | -29.83M | 70.03M | 243.54M |
Balance Sheet | ||||||
Total Assets | 2.79B | 2.74B | 2.81B | 3.03B | 3.05B | 2.23B |
Cash, Cash Equivalents and Short-Term Investments | 219.02M | 219.31M | 273.69M | 346.97M | 494.61M | 509.48M |
Total Debt | 780.53M | 847.85M | 896.19M | 1.07B | 1.29B | 516.79M |
Total Liabilities | 1.36B | 1.37B | 1.35B | 1.52B | 1.75B | 915.41M |
Stockholders Equity | 1.43B | 1.37B | 1.46B | 1.51B | 1.30B | 1.31B |
Cash Flow | ||||||
Free Cash Flow | 290.56M | 246.88M | 165.90M | -20.63M | 143.53M | 63.55M |
Operating Cash Flow | 318.78M | 295.77M | 202.91M | 10.42M | 192.20M | 107.69M |
Investing Cash Flow | -26.23M | -47.85M | 12.74M | -551.63M | -56.69M | 382.52M |
Financing Cash Flow | -258.69M | -301.80M | -288.51M | -424.48M | 676.47M | -256.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $5.20B | 23.05 | 29.85% | ― | 6.31% | 11.24% | |
77 Outperform | $2.10B | 14.16 | 16.54% | 1.62% | 6.35% | 0.35% | |
75 Outperform | $4.42B | 20.42 | 16.62% | ― | 13.10% | 127.72% | |
74 Outperform | $3.52B | 12.59 | 31.14% | ― | 1.26% | 140.30% | |
73 Outperform | $4.15B | 6.68 | 14.87% | 0.76% | 5.91% | 137.49% | |
67 Neutral | $2.02B | 17.87 | 6.86% | 2.88% | 5.72% | 11.02% | |
62 Neutral | $16.90B | 11.24 | -7.48% | 2.95% | 1.60% | -23.76% |
On May 6, 2025, Adtalem Global Education announced a new $150 million share repurchase program authorized by its board of directors, allowing the company to buy back shares through May 2028. This follows the completion of a previous $300 million repurchase program, reflecting Adtalem’s strong financial position and commitment to shareholder value. The company has returned $763 million to shareholders since February 2022, reducing shares outstanding by 28%. Adtalem aims to leverage its robust cash flow to expand healthcare education programs and continue enhancing shareholder value.